Home » Newsletters » BioWorld Science

BioWorld Science

March 22, 1999

View Archived Issues

Maxim allowed additional U.S. patent for Maxamine technology

FDA clears Uni-Gold Strep A test

Copernicus Therapeutics receives grant from NCI for novel gene therapy research

Angstrom and Diatide to develop new cancer treatments and diagnostic products

First clinical experiences reported with S-1197 and its orally active prodrugs

Cholesterol biosynthesis inhibitors in the Zeneca pipeline

Aastrom receives SBIR grant for cord blood transplant program

Agents for disorders of GABAergic transmission from Synthelabo

James Black Foundation describes new H3 ligands

Heterocyclic compounds with antitumor activity developed at Zenyaku Kogyo

News from ASCPT: first report of clinical evaluation of Schwarz's organic nitrate

Endothelin receptor antagonists for cardiovascular, renal and cerebral disorders

Hungarian research team describes GnRH receptor-targeted antitumor drug conjugates

Amgen patents novel hydroxamic acid-based MMP inhibitors

Novel tacrolimus (FK-506) prodrug expected to have superior therapeutic activity

Ono-4057: BLT receptor antagonist with beneficial effects in rat model of nephritis

Profile of CS-747, a novel antiplatelet agent from Sankyo and Ube

Design and synthesis of new CRF1 antagonist NBI-30545 presented at ACS meeting

Enrollment completed in phase III LeuTech clinical trial

Three products advance in the pipeline at Chugai

ACS highlights: Agouron and Roche present MMP inhibitor clinical candidate

FDA approves first product specifically for pain associated with postherpetic neuralgia

German launch announced for Novartis immunosuppressant

Potent, orally active CRF antagonist with anxiolytic activity reported by DuPont at ACS meeting

Gilead initiates phase III trial of adefovir dipivoxil in treatment of HBV

Compounds emerging from Neurocrine Biosciences' CRF antagonist program

Digene's DNA-based HPV test cleared for U.S. marketing

Scotia's photodynamic cancer drug receives fast track status from FDA

Synaptic updates migraine program

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...